Erik Harris

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RARE

Current role

3 calls Latest call 2026-05-05

DNLI

Current role

Board Member

2022-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Commercial Officer and Executive Vice President	$619,692	—	$2,407,560	$712,257	$291,563	$14,000	$4,045,072
2024	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Commercial Officer and Executive Vice President	$604,231	—	$2,271,944	$1,038,603	$367,235	$13,800	$4,295,813
2023	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Commercial Officer and Executive Vice President	$585,969	—	$2,169,750	$1,020,050	$279,598	$13,200	$4,068,567
2022	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Commercial Officer and Executive Vice President	$566,331	—	$2,007,768	$892,550	$269,706	$12,200	$3,748,555
2021	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Commercial Officer and Executive Vice President	$543,846	—	$1,653,212	$866,427	$245,025	$8,700	$3,317,210
2020	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Commercial Officer and Executive Vice President	$501,247	—	$723,432	$707,007	$292,613	—	$2,224,299
2019	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Commercial Officer and Executive Vice President	$418,077	—	$691,705	$962,122	$201,488	—	$2,273,392

Earnings-call appearances and filed executive appointments or departures, newest first.